Research.Patient.info

Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Study of Pembrolizumab in Combination with Carboplatin/Taxane (Paclitaxel or Nab-paclitaxel) Followed by Pembrolizumab with or without Maintenance Olaparib in the First-line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
This study is looking at new ways to treat a type of lung cancer that has spread. It combines standard chemotherapy with a newer drug, pembrolizumab, and sometimes involves another drug, olaparib, to see if this mix works better.
Germany · Austria · Spain